References
- Ministry of Health and Welfare, Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2020. Sejong: Ministry of Health and Welfare; 2020, p. 1-52.
- National Health Insurance Service, Health Insurance Review & Assessment Service, "Health Insurance Statistics", 2024 Q1, May 25, 2024, Status of Medical Institutions by Establishment Type.
- Gal P, Brabek J, Holub M, Jakubek M, Sedo A, Lacina L, et al. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation. Histochem Cell Biol 2022;158(5):415-34.
- Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol 2016 Sep;37(9):11553-72.
- Gosain R, Anwar S, Miller A, Iyer R, Mukherjee S. Interleukin-6 as a biomarker in patients with hepatobiliary cancers. J Gastrointest Oncol 2019;10(3):537-45.
- Masjedi A, Hashemi V, Hojjat-Farsangi M, Ghalamfarsa G, Azizi G, Yousefi M, et al. The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother 2018;108:1415-24.
- Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, et al. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer 2005;8(2):124-31.
- Kishimoto T. Factors affecting B-cell growth and differentiation. Annu Rev Immunol 1985;3:133-57.
- Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol 2014;6(10):a016295-a.
- Briukhovetska D, Dorr J, Endres S, Libby P, Dinarello CA, Kobold S. Interleukins in cancer: from biology to therapy. Nat Rev Cancer 2021;21(8):481-99.
- Raskova M, Lacina L, Kejik Z, Venhauerova A, Skalickova M, Kolar M, et al. The Role of IL-6 in Cancer Invasiveness and Metastasis-Overview and Therapeutic Opportunities. Cells 2022;11(22):3698.
- Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, et al. Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance. Cancer Res 2013 Oct;72(20):6359-74.
- Van Duijneveldt G, Michael, Putoczki TL. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clin Sci (Lond) 2020;134(16):2091-115.
- Kim HW, Lee JC, Paik KH, Kang J, Kim J, Hwang JH. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern. Medicine (Baltimore) 2017;96(5):e5926.